Consolidated Balance Sheet - USD ($) $ in Millions	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Current assets
Cash and cash equivalents	$ 225.7	$ 209.1	$ 216.4	$ 188.7
Trade receivables	137.8	109.4
Inventory, Net	484.7	477.3
Other current assets	147.3	140.2
Total current assets	995.5	936.0
Property, Plant and Equipment, Net	369.3	349.1
Goodwill	1,291.1	1,338.6	1,331.4
Other intangible assets, net	921.3	948.5
Other assets	179.1	158.7
Total assets	3,756.3	3,730.9
Current liabilities
Notes payable	29.5	24.5
Accounts payable	219.7	219.3
Other current liabilities	316.3	319.8
Total current liabilities	565.5	563.6
Long-term debt	1,383.3	1,275.0
Deferred income tax liabilities	118.8	133.2
Other liabilities	135.6	175.0
Total liabilities	2,203.2	2,146.8
Shareholders’ equity
Common shares	0.7	0.7
Additional paid-in capital	1,578.8	1,586.0
Retained earnings	1,086.7	1,090.1
Common shares in treasury at cost	(1,003.3)	(937.9)
Accumulated other comprehensive loss	(109.8)	(154.8)
Total shareholders’ equity	1,553.1	1,584.1	$ 1,540.5	$ 1,467.1
Total liabilities and shareholders’ equity	$ 3,756.3	$ 3,730.9
Common shares, par value (in usd per share)	$ 0.01	$ 0.01
Common shares, issued (in shares)	65,251,989	65,251,989
Common shares, outstanding (in shares)	46,464,244	48,920,813
Common shares, authorized (in shares)	300,000,000	300,000,000
Treasury shares (in shares)	18,787,745	16,331,176
Preferred shares, authorized (in shares)	10,000,000.0	10,000,000.0
Preferred shares, par value (in usd per share)	$ 0.01	$ 0.01
Preferred shares, outstanding (in shares)	0	0